TG Therapeutics, Inc. (TGTX)
64.48
-0.08
(-0.12%)
USD |
NASDAQ |
Nov 13, 16:00
64.48
0.00 (0.00%)
After-Hours: 19:59
TG Therapeutics Total Assets (Quarterly) : 1.592B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.592B |
| June 30, 2026 | 1.640B |
| March 31, 2026 | 1.529B |
| December 31, 2025 | 1.063B |
| September 30, 2025 | 1.025B |
| June 30, 2025 | 702.61M |
| March 31, 2025 | 656.69M |
| December 31, 2024 | 577.69M |
| September 30, 2024 | 586.01M |
| June 30, 2024 | 401.21M |
| March 31, 2024 | 373.32M |
| December 31, 2023 | 329.59M |
| September 30, 2023 | 331.07M |
| June 30, 2023 | 220.85M |
| March 31, 2023 | 197.36M |
| December 31, 2022 | 193.57M |
| September 30, 2022 | 217.89M |
| June 30, 2022 | 251.67M |
| March 31, 2022 | 303.03M |
| December 31, 2021 | 379.63M |
| September 30, 2021 | 409.69M |
| June 30, 2021 | 481.40M |
| March 31, 2021 | 548.70M |
| December 31, 2020 | 625.64M |
| September 30, 2020 | 273.86M |
| Date | Value |
|---|---|
| June 30, 2020 | 294.62M |
| March 31, 2020 | 101.85M |
| December 31, 2019 | 163.01M |
| September 30, 2019 | 93.33M |
| June 30, 2019 | 106.58M |
| March 31, 2019 | 117.54M |
| December 31, 2018 | 83.62M |
| September 30, 2018 | 114.37M |
| June 30, 2018 | 140.72M |
| March 31, 2018 | 120.99M |
| December 31, 2017 | 97.38M |
| September 30, 2017 | 101.78M |
| June 30, 2017 | 101.20M |
| March 31, 2017 | 123.26M |
| December 31, 2016 | 54.78M |
| September 30, 2016 | 75.69M |
| June 30, 2016 | 94.80M |
| March 31, 2016 | 100.06M |
| December 31, 2015 | 113.47M |
| September 30, 2015 | 127.41M |
| June 30, 2015 | 123.61M |
| March 31, 2015 | 117.27M |
| December 31, 2014 | 86.75M |
| September 30, 2014 | 77.54M |
| June 30, 2014 | 56.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 5.267B |
| Vertex Pharmaceuticals, Inc. | 32.74B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Insmed, Inc. | 2.226B |
| Ionis Pharmaceuticals, Inc. | 2.913B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.020B |
| Shareholders Equity (Quarterly) | 572.13M |
| Debt to Equity Ratio | 1.318 |
| Current Ratio | 4.496 |
| Net Debt Paydown Yield | -1.19% |